Shenzhen Bioeasy Biotechnology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021
October 27, 2021 at 03:06 pm IST
Share
Shenzhen Bioeasy Biotechnology Co., Ltd. reported earnings results for the nine months ended September 30, 2021. For the nine months, the company reported sales was CNY 431.07 million compared to CNY 186.49 million a year ago. Revenue was CNY 431.07 million compared to CNY 186.49 million a year ago. Net income was CNY 195.66 million compared to CNY 51.9 million a year ago. Basic earnings per share from continuing operations was CNY 0.4994 compared to CNY 0.14 a year ago. Diluted earnings per share from continuing operations was CNY 0.4994 compared to CNY 0.14 a year ago.
Shenzhen Bioeasy Biotechnology Co Ltd is a China-based company mainly engaged in the research, development, production, sales and provision of food safety testing products and related services. The Companyâs main products are food safety rapid testing reagents, rapid testing instruments, related testing services and in vitro diagnostic point-of-car testing (POCT) products, such as colloidal gold immunochromatographic test papers, enzyme-linked immunoassay (ELISA) kits, nucleic acids extraction kit, portable food rapid analysis system, infectious disease detection series and fluorescence immunoassay analyzer, etc. Its products are mainly used in dairy, meat, aquatic products, grains and oils, fruits and vegetables and other food fields that require rapid testing, as well as in the cultivation and breeding fields.
SHENZHEN BIOEASY BIOTECHNOLOGY CO., LTD. 
